LAUREN WILLIS: Open Payments
NPI 1528723913 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,911 in 112 payments from 19 companies in 2025. Trend: 2023 $1,383 · 2024 $2,287 · 2025 $1,911
Food & beverage: $1,911
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 28 | $370 |
| Amgen Inc. | 16 | $274 |
| E.R. Squibb & Sons, L.L.C. | 16 | $219 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $179 |
| Novo Nordisk Inc | 8 | $150 |
| Boston Scientific Corporation | 4 | $147 |
| PFIZER INC. | 7 | $137 |
| Alnylam Pharmaceuticals Inc. | 5 | $91 |
| AstraZeneca Pharmaceuticals LP | 5 | $73 |
| United Therapeutics Corporation | 2 | $44 |
Products named: LEQVIO, REPATHA, LifeVest, CAMZYOS, Wegovy, ACCOLADE SR, ELIQUIS, AMVUTTRA.
Industry payments across MO — which companies pay providers there.
